Bilirubin possesses powerful immunomodulatory activity and suppresses experimental autoimmune encephalomyelitis - PubMed (original) (raw)
Bilirubin possesses powerful immunomodulatory activity and suppresses experimental autoimmune encephalomyelitis
Yingru Liu et al. J Immunol. 2008.
Abstract
Bilirubin, an abundant bile pigment in mammalian serum, was once considered a toxic waste product and has more recently been recognized as a potent antioxidant of physiological importance. However, its potential biological functions in other fields are not well understood. Herein we show that bilirubin is also a powerful immunomodulatory agent. Bilirubin significantly inhibited Ag-specific and polyclonal T cell responses, while other similar antioxidants completely lacked this effect. Bilirubin suppressed CD4(+) T cell responses at multiple steps. High levels of bilirubin could induce apoptosis in reactive CD4(+) T cells. Bilirubin at nonapoptotic concentrations suppressed CD4(+) T cell reactivity through a wide range of actions, including inhibition of costimulator activities, suppression of immune transcription factor activation, and down-regulation of inducible MHC class II expression. Further studies suggest that bilirubin actions were direct, rather than via induction of immune deviation or regulatory T cells. In vivo, treatment with bilirubin effectively suppressed experimental autoimmune encephalomyelitis in SJL/J mice. In contrast, depletion of endogenous bilirubin dramatically exacerbated this disease. In summary, our results identify bilirubin as an important immunomodulator that may protect mammals against autoimmune diseases, thereby indicating its potential in the treatment of multiple sclerosis and other immune disorders.
Similar articles
- Predicting the effects of potentially therapeutic modified peptides on polyclonal T cell populations in a mouse model of multiple sclerosis.
Sauer EL, Trifilieff E, Greer JM. Sauer EL, et al. J Neuroimmunol. 2017 Jun 15;307:18-26. doi: 10.1016/j.jneuroim.2017.03.011. Epub 2017 Mar 21. J Neuroimmunol. 2017. PMID: 28495132 - Triptolide modulates T-cell inflammatory responses and ameliorates experimental autoimmune encephalomyelitis.
Wang Y, Mei Y, Feng D, Xu L. Wang Y, et al. J Neurosci Res. 2008 Aug 15;86(11):2441-9. doi: 10.1002/jnr.21683. J Neurosci Res. 2008. PMID: 18438925 - The immunosuppressive effects of bilirubin.
Vĕtvicka V, Síma P, Miler I, Bilej M. Vĕtvicka V, et al. Folia Microbiol (Praha). 1991;36(2):112-9. doi: 10.1007/BF02814488. Folia Microbiol (Praha). 1991. PMID: 1823644 Review.
Cited by
- The Prognostic Index Independently Predicts Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Resection.
Gruber ES, Jomrich G, Kaider A, Gnant M, Sahora K, Schindl M. Gruber ES, et al. Ann Surg Oncol. 2020 Jun;27(6):2017-2024. doi: 10.1245/s10434-019-08161-6. Epub 2020 Jan 3. Ann Surg Oncol. 2020. PMID: 31900809 Free PMC article. - The mildly elevated serum bilirubin level is negatively associated with the incidence of end stage renal disease in patients with IgA nephropathy.
Chin HJ, Cho HJ, Lee TW, Na KY, Oh KH, Joo KW, Yoon HJ, Kim YS, Ahn C, Han JS, Kim S, Jeon ES, Jin DC, Kim YL, Park SH, Kim CD, Song YR, Kim SG, Kim YG, Lee JE, Oh YK, Lim CS, Lee SK, Chae DW, Cho WY, Kim HK, Jo SK; Progressive REnal disease and Medical Informatics and gEnomics Research (PREMIER) members. Chin HJ, et al. J Korean Med Sci. 2009 Jan;24 Suppl(Suppl 1):S22-9. doi: 10.3346/jkms.2009.24.S1.S22. Epub 2009 Jan 28. J Korean Med Sci. 2009. PMID: 19194557 Free PMC article. - Heme Oxygenase Dependent Bilirubin Generation in Vascular Cells: A Role in Preventing Endothelial Dysfunction in Local Tissue Microenvironment?
Nitti M, Furfaro AL, Mann GE. Nitti M, et al. Front Physiol. 2020 Jan 29;11:23. doi: 10.3389/fphys.2020.00023. eCollection 2020. Front Physiol. 2020. PMID: 32082188 Free PMC article. Review. - Combined prognostic nutritional index and albumin-bilirubin grade to predict the postoperative prognosis of HBV-associated hepatocellular carcinoma patients.
Liang X, Liangliang X, Peng W, Tao Y, Jinfu Z, Ming Z, Mingqing X. Liang X, et al. Sci Rep. 2021 Jul 16;11(1):14624. doi: 10.1038/s41598-021-94035-5. Sci Rep. 2021. PMID: 34272447 Free PMC article. - Decreased Bilirubin is Associated With Disease Activity of Primary Sjögren's Syndrome.
Xie J, Zhang Z, Liang Y, Yang Z. Xie J, et al. Arch Rheumatol. 2020 Jan 8;35(3):351-356. doi: 10.46497/ArchRheumatol.2020.7633. eCollection 2020 Sep. Arch Rheumatol. 2020. PMID: 33458658 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials